SEC Form D private-offering filing
ILIAD BIOTECHNOLOGIES, INC.
A new SEC Form D private-offering notice from Weston, FL, a $115,540,057 filer-stated offering target in Biotech. The source filing is one click away.
Clinical stage biotech developing BPZE1, a live attenuated intranasal vaccine for pertussis (whooping cough)
Filed 2026-02-20Filed to raise $115,540,057First money in 2026-02-05Raised so far $115,540,057HQ (as filed) Weston, FLSector Biotech ✓Stage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified iliadbio.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.